Johnson & Johnson on Tuesday mentioned it had reached a tentative settlement to resolve probes by U.S. states into whether or not it misled shoppers in regards to the security of its talc merchandise, which 1000’s of lawsuits declare may cause most cancers.
The deal consists of 42 states and Washington, D.C. The corporate tentatively agreed to pay about $700 million to settle the states’ claims, in response to the Wall Avenue Journal.
“According to the plan we outlined final 12 months, the corporate continues to pursue a number of paths to attain a complete and remaining decision of the talc litigation,” Erik Haas, J&J’s worldwide vice chairman of litigation, mentioned in an announcement.
The settlement doesn’t prolong to personal plaintiffs’ instances in opposition to the corporate, a few of that are anticipated to go to trial later this 12 months.
J&J has maintained that its now-discontinued talc merchandise are protected and don’t trigger most cancers. It beforehand put aside $400 million to resolve state claims.
The corporate, which reported fourth-quarter outcomes on Tuesday, nonetheless faces greater than 50,000 lawsuits over talc, most by ladies with ovarian most cancers. A minority of the instances contain folks with mesothelioma, a sort of most cancers linked to asbestos. It not too long ago settled a few of the mesothelioma instances for an undisclosed quantity however has maintained that its talc didn’t comprise asbestos.
The corporate has twice tried to resolve the instances by inserting its talc liabilities out of business, however each makes an attempt had been rebuffed by courts.
Within the newest failed chapter try, the corporate had proposed to pay $8.9 billion to talc claimants. J&J mentioned final 12 months that it was planning a 3rd chapter submitting.
The settlement with the states may make that simpler, as some states had beforehand argued that they, in contrast to personal plaintiffs, can proceed pursuing claims whereas a chapter is pending. Courts haven’t resolved that problem.
Trials within the talc instances have had a blended document, with main plaintiff wins together with a $2.1 billion judgment in 2020 awarded to 22 ladies with ovarian most cancers.
A New Jersey appeals court docket in October threw out a $223.8 million verdict in opposition to the corporate, discovering the testimony of the plaintiffs’ skilled witnesses unsound.
The corporate stopped promoting talc-based child powder in favor of cornstarch-based merchandise, citing a rise in lawsuits and “misinformation” in regards to the talc product’s security.
An important insurance coverage information,in your inbox each enterprise day.
Get the insurance coverage trade’s trusted e-newsletter